Antiviral — nucleoside analogue (herpes zoster treatment)
Pregnancy: Use with caution — oral aciclovir used in pregnancy for zoster; benefits generally outweigh risks. Topical aciclovir considered safe.
Aciclovir 800mg Tablets (Ramsay Hunt Syndrome / Herpes Zoster Oticus)
Brand names: Zovirax, Aciclovir generic
Adult dose
Dose: 800 mg five times daily for 7 days
Route: Oral
Frequency: Five times daily (every 4 hours while awake; omit one night-time dose)
Max: 4000 mg/day (800 mg × 5)
Ramsay Hunt syndrome (herpes zoster oticus with facial nerve involvement): 800 mg 5 times daily for 7–10 days, ideally started within 72 hours of rash onset. Combine with prednisolone 40–60 mg once daily for 7 days (tapered) for best facial nerve outcomes. If unable to swallow: IV aciclovir under specialist care. Adequate hydration essential to reduce nephrotoxicity risk.
Paediatric dose
Route: Oral
Frequency: Five times daily
Max: 800 mg per dose
Ramsay Hunt in children: uncommon. Aciclovir 800 mg 5×/day for children ≥12 years (adult dose). Under 12 years: specialist guidance — weight-based dosing (250 mg/m² IV or specialist oral dosing). Varicella-zoster in immunocompromised children: IV aciclovir preferred.
Dose adjustments
Renal
eGFR 25–50: 800 mg every 8 hours. eGFR 10–25: 800 mg every 12 hours. eGFR <10: 800 mg every 24 hours. Ensure adequate hydration.
Hepatic
No dose adjustment required.
Clinical pearls
- Start within 72 hours of rash for maximal benefit — delay beyond 72 hours reduces efficacy significantly
- Always combine with systemic corticosteroids (prednisolone) for Ramsay Hunt — combined therapy superior to antiviral alone for facial nerve recovery
- Valaciclovir 1 g TDS for 7 days is an alternative with better bioavailability and simpler regimen (once licensed)
- Ramsay Hunt carries worse prognosis for complete facial nerve recovery compared to Bell's palsy — refer to ENT urgently
- Incomplete eye closure (lagophthalmos): prescribe artificial tears and tape eye shut at night — corneal exposure keratopathy risk
Contraindications
- Hypersensitivity to aciclovir or valaciclovir
- Severe dehydration (increases nephrotoxicity risk)
Side effects
- Nausea and vomiting
- Headache
- Nephrotoxicity (crystalluria — especially with dehydration; maintain adequate fluid intake)
- Dizziness and confusion (high doses or renal impairment)
- Rash
- Elevated transaminases
Interactions
- Probenecid and cimetidine — reduce renal clearance of aciclovir (increased plasma levels)
- Mycophenolate mofetil — additive immunosuppressant considerations
- Nephrotoxic drugs — additive renal toxicity risk
Monitoring
- Renal function (U&E) during treatment
- Facial nerve function (Sunnybrook or House-Brackmann grading)
- Hearing and vestibular function
Reference: BNFc; BNF; NICE CKS Shingles; ENT-UK Ramsay Hunt Guidelines; Cochrane Review Zoster. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Ramsay Sedation Scale · Sedation
- Ramsay Sedation Scale · Sedation Assessment
- Corrected QT Interval (Bazett) · ECG
- HEART Score for Major Adverse Cardiac Events · Chest Pain
- DOAC Score for Selecting Direct Oral Anticoagulant in Non-Valvular AF · Anticoagulation
- Bazett Corrected QT Interval (QTc) Calculator · Arrhythmia
Pathways
- Adult Upper Airway Obstruction (Stridor) · DAS 2015 unanticipated difficult airway; RCEM
- Epistaxis Management · ENT-UK / NICE
- Acute Otitis Media · NICE NG91 2018
- Tonsillitis and Sore Throat · NICE NG84 2018
- Benign Paroxysmal Positional Vertigo · NICE CG124 / AAO-HNS Guidelines
- Acute Rhinosinusitis · NICE NG79 2017 / EPOS 2020